Biomedical subjects

Andrzej Zarowski

Publications and source records attributed to Andrzej Zarowski.

3 recordsLinked to original sources

PubMed2006

Stapedotomy with microdrill or carbon dioxide laser: influence on inner ear function.

OBJECTIVES: A prospective randomized audiological analysis of 336 otosclerosis operations was conducted to compare the evolution of bone conduction thresholds after primary stapedotomy with two different techniques to open the footplate: microdrill and carbon dioxide laser stapedotomy. METHODS: To monitor the inner ear function, we compared the preoperative bone conduction thresholds with the postoperative levels at day 2, week 2, week 6, and month 6. Evolution of the bone conduction was compared for the two studied groups (laser versus microdrill). RESULTS: An average bone conduction loss of 1.8 dB was measured at day 2 for the middle frequencies (0.5, 1, and 2 kHz). At 4 kHz, a bone conduction loss of 7 dB was found. The bone conduction thresholds measured in the first and second months after surgery showed a gradual recovery with overclosure as the end result. CONCLUSIONS: Our results confirm the transient depression of inner ear function in the immediate postoperative period, with recovery within the first weeks after surgery. In the studied population, no statistically significant difference was found between the two techniques that were used to make the calibrated hole (laser versus microdrill). These results demonstrate that both techniques possess the same early effect regarding inner ear function. The authors hypothesize that an early inflammatory reaction could be the cause of the transient bone conduction shift.

Adolescent↗

PubMed2004

The facial nerve canal: an important cochlear conduction path revealed by Clarion electrical field imaging.

HYPOTHESIS: Electrical properties of the implanted scala tympani could be accurately modeled by means of a simple resistive ladder network model. The subject-specific model parameters can be obtained from electrical field imaging (EFI) recordings. It is a powerful tool for analysis of the cochlear current spread. BACKGROUND: In EFI mode, the telemetry systems of contemporary cochlear implants can measure the intracochlear potential distribution. At present, the clinical use of EFI is typically limited to checking the implant's proper functioning. METHODS: Accurate EFI measurements and estimation algorithms have been developed to fit a small, yet physically relevant electrical model of the conductivity of the intracochlear structures. RESULTS: The model can attain up to 95% agreement with in vivo EFI data. A first discovery is that in a majority of the tested subjects, a substantial fraction of the monopolar current leaves the scala along the facial nerve canal. The role of the facial nerve canal has been confirmed by a temporal bone study and a high-resolution computed tomography (HRCT) scan in two of the implanted subjects. CONCLUSIONS: The clinical use of EFI is not limited to checking the implant's status. For the Clarion II implant, a purely resistive model is able to match in vivo EFI recordings. The model indicates that the facial nerve canal is an important conduction path to the reference electrode. EFI can provide clinically relevant information, especially in problematic cases of cochlear malformations, postoperative fibrosis/ossification, implanted otosclerotic cochleae, postoperative facial nerve stimulation, increased stimulation thresholds, and so on.

Algorithms↗

PubMed2003

Radiotherapy-induced ear toxicity.

Despite their particular functional consequences, radiotherapy-induced ear injuries remain under-evaluated and under-reported. These reactions may have acute or late character, may affect all structures of the hearing organ, and result in conductive, sensorineural or mixed hearing loss. Up to 40% of patients have acute middle ear side effects during radical irradiation including acoustic structures and about one-third of patients develop late sensorineural hearing loss (SNHL). Total radiotherapy dose and tumour site seem to be among the most important factors associated with the risk of hearing impairment. Thus, reduction in radiation dose to the auditory structures should be attempted whenever possible. New radiotherapy techniques (3-dimensional conformal irradiation, intensity modulated radiotherapy, proton therapy) allow better dose distribution with lower dose to the non-target organs. Treatment of acute and late external otitis is mainly conservative and includes the anti-inflammatory agents (applied topically and systematically). Post-radiation chronic otitis media and the eustachian tube pathology may be managed with tympanic membrane incision with insertion of a tympanostomy tube (grommet), although the benefit of such approach is controversial and some authors advocate a more conservative approach. In these patients the functional deficit can be alleviated by application of bone conduction hearing aids such as, e.g., the bone anchored hearing aid (BAHA). There is no standard therapy for post-irradiation sudden or progressive SNHL yet corticosteroid therapy, rheologic medications, hyperbaric oxygen or carbogen therapy are usually employed (as for idiopathic SNHL), although controversial data on the efficacy of these treatment modalities have been published. In selected cases with bilateral profound hearing loss or total deafness, cochlear implants may prove effective. Further improvements in radiotherapy techniques and progress in otologic diagnostics and therapy may allow better prevention and management of radiation-related acoustic injury.

Audiometry↗